Hepatitis C Drug Market for Hospitals, Private labs, Physician Offices, Public Health Labs and Blood Banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global Hepatitis C drug market worth $33.50 by 2022, growing at a CAGR of 16.0% between 2017 and 2022.

16-Mar-2017 | Number of pages: 110 | Report Code: ZMR-1326 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Hepatitis C drug market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the Hepatitis C drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hepatitis C drug market on a global level.

This report offers comprehensive coverage on global Hepatitis C drug market along with, market trends, drivers, and restraints of Hepatitis C drug market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the Hepatitis C drug market has also been included. The study encompasses a market attractiveness analysis, wherein each segment are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the Hepatitis C drug market by segmenting the market based on End-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. The End-user market covered under this study includes hospitals, private labs, physician offices, public health labs and blood bank. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., U.K., Germany, France, Japan, China, India, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global Hepatitis C drug market include Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

This report segments the global Hepatitis C drug market as follows:

Global Hepatitis C Drug Market:  End-User Analysis

  • Hospitals
  • Private labs
  • Physician offices
  • Public health labs
  • Blood Bank

Global Hepatitis C Drug Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Veterinary Anti-Infectives Market by Species Type (Livestock and Companion), by Drug Class (Antimicrobial, Antiviral, Antifungal and Antiparasitic Agents), by Mode of Administration (Oral, Parenteral and Topical) and End-users (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2510 | Report Format:

The report covers forecast and analysis for the veterinary anti-infectives market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the veterinary anti-infectiv...Read More

Acromegaly Treatment Market by Disease type (Ectopic Acromegaly and Pseudo Acromegaly), Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2507 | Report Format:

The report covers forecast and analysis for the acromegaly treatment market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the acromegaly treatment market al...Read More

year end sale
Choose License Type:
Latest Published Reports

View All Published Reports